Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2017-02-01
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
NCT06615349
Early, Integrated, Specialized Palliative Rehabilitation
NCT02332317
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients
NCT00253383
Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
NCT05984797
Therapeutic Support to Strengthen Dignity, Mental Well-being and Quality of Life in Acute Palliative Care Patients.
NCT06549075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile Health
Patients discharged from hospital will be equipped with a tracking bracelet and a smart phone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Karnofsky Index ≥50%
* ECOG≤ 2
* aged \> 18 years
* passed a short handling test with devices (tracking bracelet, smart phone)
Exclusion Criteria
* insufficient knowledge of German language.
18 Years
105 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Federal Institute of Technology
OTHER
Swiss Academy of Medical Sciences (SAMS)
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Guckenberger, Prof
Role: STUDY_CHAIR
Clinic of Radiation-Oncology USZ
Gerhard Tröster, Prof
Role: STUDY_CHAIR
ETH Zürich
Gudrun Theile, MD
Role: PRINCIPAL_INVESTIGATOR
Clinic of Radiation-Oncology USZ
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic of Radiation-Oncology University Hospital Zurich
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PC 16/16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.